Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-05-23

FDA Approved: ESZOPICLONE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

Eszopiclone received FDA approval via its original application for the treatment of insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lunesta (eszopiclone)

Snippet

ORIG AP for ESZOPICLONE (ESZOPICLONE)